Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-25-097267

EVP, COO acquired 5 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Lamothe Jeffrey G. EVP, COO 2025-07-17 Option exercise +5 6 D
Derivatives
Lamothe Jeffrey G. EVP, COO 2025-07-17 Option exercise · Restricted Stock Unit −5 12 D
Loading xslF345X05/ownership.xml…